(Q46819343)

25 December 2017

title

Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy (English)

1 reference

25 December 2017

author

John Cleland

1

1 reference

25 December 2017

author name string

Alison P Coletta

2

1 reference

25 December 2017

Ahmed Tageldien Abdellah

3

1 reference

25 December 2017

Damien Cullington

4

1 reference

25 December 2017

Andrew L Clark

5

1 reference

25 December 2017

Alan S Rigby

6

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

European Journal of Heart Failure

published in

1 reference

25 December 2017

volume

10

1 reference

25 December 2017

page(s)

102-108

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

The relationship between cholesterol and survival in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

The meaning of patient participation for patients and nurses at a nurse-led clinic for chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to R

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.004

10.1016/J.EJHEART.2007.12.004

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

release_wp7ij5abbnftlmjvsnusbwdpji

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wp7ij5abbnftlmjvsnusbwdpji

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18179987

1 reference

25 December 2017